Physician profile
Paul R Clark
NPI 1619388659
$4,718.07
in general payments reported to CMS, 2019-2025
19 companies · $811 in 2025
The $811 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,089 · 2022: $799 · 2023: $397 · 2024: $1,622 · 2025: $811.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,901 · Travel and Lodging: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,900.83 |
| Travel and Lodging | $929.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,957.10 | 2021-2025 | Cd Horizon Spinal System, Mazor X System, Unid_pass |
| Providence Medical Technology, INC. | $508.04 | 2021-2024 | |
| Spineology INC. | $340.99 | 2024-2025 | Optimesh Expandable Interbody Fusion System |
| Depuy Synthes Sales INC. | $261.12 | 2021-2025 | Viper, Velys, Fibergraft Bg Morsels |
| Orthofix Medical, INC. | $144.71 | 2021-2025 | Cervical-Stim |
| Nuvasive, INC. | $119.90 | 2021 | |
| 4web, INC. | $47.81 | 2022 | |
| Cerapedics INC. | $44.89 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Kls-Martin L.P. | $40.52 | 2022-2023 | |
| Baxter Healthcare | $38.90 | 2023 | Floseal |
| Ossdsign USA Incorporated | $31.97 | 2025 | Ossdsign Catalyst |
| Edwards Lifesciences Corporation | $31.57 | 2025 | Mitris Resilia Mitral Valve |
| Globus Medical, INC. | $26.34 | 2022-2023 | Sable |
| Ethicon US, LLC | $23.14 | 2022 | |
| Integra Lifesciences Corporation | $23.11 | 2024 | Integra, Microfrance, Integra Duo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $21.00 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Djo, LLC | $20.87 | 2024 | Cmf |
| Vertex Pharmaceuticals Incorporated | $19.84 | 2025 | |
| Spinal Elements, INC. | $16.25 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.